Medical Device News

Medical Device News Magazine delivers the latest medical device news and MedTech industry updates from medical device manufacturers, healthcare organizations, researchers, innovators and technology companies worldwide. Our coverage follows the technologies, companies, regulatory developments and clinical advances shaping the rapidly evolving global medical device industry.

Stay informed about new medical devices, product launches, FDA approvals and clearances, medical device clinical trials, medical imaging technologies, artificial intelligence, digital health, cardiovascular devices, surgical technologies, diagnostics, patient monitoring systems, robotics and other emerging medical technologies designed to advance patient care and clinical practice.

Our coverage extends beyond product innovation to include the business and regulatory developments influencing the medical device industry. Medical Device News Magazine reports on FDA regulatory developments, 510(k) clearances, Premarket Approvals (PMA), medical device recalls and safety information, funding and investment, mergers and acquisitions, executive appointments, strategic partnerships and market developments affecting established manufacturers and emerging MedTech companies.

As healthcare becomes increasingly connected, data-driven and technology-focused, Medical Device News Magazine provides timely industry information for medical specialists, healthcare professionals, medical device executives, investors and other MedTech stakeholders who want to understand the technologies and companies influencing the future of healthcare.

Explore the latest Medical Device News below for updates on innovative medical technologies, FDA regulatory milestones, clinical research, product introductions, industry partnerships and companies developing the next generation of medical devices.

Pulmatrix Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation

Ted Raad, Chief Executive Officer of Pulmatrix, commented, “MannKind’s interest in iSPERSE™ validates the enablement potential of our innovative particle engineering dry powder technology. In addition, the assumption of our lease and laboratory by MannKind helps extend our cash runway further into 2026. We are able to build upon this agreement to further support development of PUR3100 and its potential application with MannKind’s Cricket® device to develop the 1st orally inhaled DHE treatment for acute migraine.”

Read More »